Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Research and development spending
3Y CAGR
+40.4%/yr
vs +39.3%/yr prior
5Y CAGR
+59.8%/yr
Recent deceleration
Acceleration
+1.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
10.4x
Strong expansion
Streak
5 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $85.86M | +6.3% |
| 2024 | $80.78M | +25.1% |
| 2023 | $64.57M | +108.2% |
| 2022 | $31.02M | +51.5% |
| 2021 | $20.47M | +148.5% |
| 2020 | $8.24M | -56.7% |
| 2019 | $19.01M | +130.7% |
| 2018 | $8.24M | +4.1% |
| 2017 | $7.92M | - |